Combined genetic mutations have remarkable effect on deep venous thrombosis and/or pulmonary embolism occurence

Gene

Volumn 536, Issue 1, 2014, Pages 171-176

  Simsek, Erdal ^a   Yesilyurt, Ahmet ^b   Pinarli, Ferda ^b   Eyerci, Nilnur ^b   Ulus, A Tulga ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Deep venous thrombosis; Genetic mutation; Pulmonary embolism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ADULT; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUTATION RATE; PATHOGENESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 84891827678     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.11.019     Document Type: Article

References (28)

1. Akar N., Misirlioglu M., Akar E., Avcu F., Yalçin A., et al. Prothrombin gene 20210 G-A mutation in the Turkish population. Am. J. Hematol. 1998, 58:249.
2. Anderson F.A., Wheeler H.B., Goldberg R.J., Hosmer D.W., Patwardhan N.A., et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch. Intern. Med. 1991, 15:933-938.
3. Bertina R.M. Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin. Chem. 1997, 43:1678-1683.
4. Bezemer I.D., Doggen C.J., Vos H.L., Rosendaal F.R. No association between the common MTHFR 677C→T polymorphism and venous thrombosis: result from the MEGA study. Arch. Intern. Med. 2007, 167:497-501.
5. Carp H., Salomon O., Seidman D., Dardik R., Rosenberg N., et al. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum. Reprod. 2002, 17:1633-1637.
6. Dahlbäck B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood 2008, 112:19-27.
7. Dentali F., Galli M., Gianni M., Ageno W. Inherited thrombophilic abnormalities and risk of portal vein thrombosis. A meta-analysis. Thromb. Haemost. 2008, 99:675-682.
8. Dölek B., Eraslan S., Eroglu S., Kesim B.E., Ulutin T., et al. Molecular analysis of Factor V Leiden, Factor V Hong Kong, Factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients. Clin. Appl. Thromb. Hemost. 2007, 13:435-438.
9. Emmerich J., Rosendaal F.R., Cattaneo M., Marqaqlione M., De Stefano V., et al. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism-pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-analysis in Venous Thromboembolism. Thromb. Haemost. 2001, 86:809-816.
10. Franco R.F., Trip M.D., ten Cate H., van den Ende A., Prins M.H., et al. The 20210G→A mutation in the 3'-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. Br. J. Haematol. 1999, 104:50-54.
11. Kreidy R., Irani-Hakime N. Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients?. Vasc. Health Risk Manag. 2009, 5:627-633.
12. Mansfield M.W., Stickland M.H., Grant P.J. Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasians patients, with non insulin dependent diabetes mellitus. Thromb. Haemost. 1995, 74:842-847.
13. Naushad S., Jamal N.J., Angalena R., Prasad C.K., Devi A.R. Hyperhomocysteinemia and the compound heterozygous state for methylenetetrahydrofolate reductase are independent risk factors for deep vein thrombosis among South Indians. Blood Coagul. Fibrinolysis 2007, 18:113-117.
14. Nizankowska-Mogilnicka E., Adamek L., Grzanka P., Domagala T.B., Sanak M., et al. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis. Eur. Respir. J. 2003, 21:25-30.
15. Ohira T., Cushman M., Tsai M.Y., Zhang Y., Heckbert S.R., et al. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J. Thromb. Haemost. 2007, 5:1455-1461.
16. Poort S.R., Rosendaal F.R., Reitsma P.H., Bertina R.M. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996, 88:3698-3703.
17. Rehak M., Rehak J., Muller M., Faude S., Faude F., et al. The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis. Thromb. Haemost. 2008, 99:925-929.
18. Ridker P.M., Hennekens C.H., Lindpaintner K., Stampfer M.J., Miletich J.P. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor in a large cohort of US men. Circulation 1997, 95:59-62.
19. Ridker P.M., Hennekens C.H., Miletich J.P. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 1999, 99:999-1004.
20. Ringwald J., Berger A., Adler W., Kraus C., Pitto R.P. Genetic polymorphisms in venous thrombosis and pulmonary embolism after total hip arthroplasty. Clin. Orthop. Relat. Res. 2009, 467:1507-1515.
21. Sabbagh A.S., Mahfoud Z., Taher A., Zaatari G., Daher R., et al. High prevalence of MTHFR gene A 1298 C polymorphism in Lebanon. Genet. Test. 2008, 12:75-80.
22. Simioni P., Tormene D., Spiezia L., Tognin G., Rossetto V., et al. Inherited thrombophilia and venous thromboembolism. Semin. Thromb. Hemost. 2006, 32:700-708.
23. Sode B.F., Allin K.H., Dahl M., Gyntelberg F., Nordestgaard B.G. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type. CMAJ 2013, 185:229-237.
24. Spiezia L., Tormene D., Pesavento R., Salmaso L., Simioni P., et al. Thrombophilia as a predictor of persistent residual vein thrombosis. Haematologica 2008, 93:479-480.
25. Tug E., Aydin H., Kaplan E., Dogruer D. Frequency of genetic mutations associated with thromboembolism in the Western Black Sea Region. Intern. Med. 2011, 50:17-21.
26. Weischer M., Juul K., Zacho J., Jensen G.B., Steffensen R., et al. Prothrombin and risk of venous thromboembolism, ischemic heart disease and ischemic cerebrovascular disease in the general population. Atherosclerosis 2010, 208:480-483.
27. Wells P.S., Anderson D.R., Rodger M., Ginsberg J.S., Kearon C., et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb. Haemost. 2000, 83:416-420.
28. Zalavras ChG., Giotopoulou S., Dokou E., Mitsis M., loannou H.V., et al. Lack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece. Int. Angiol. 2002, 21:268-271.